Healios K.K. (TYO:4593)
Japan · Delayed Price · Currency is JPY 363.00
-18.00 (-4.72%)
At close: Feb 6, 2026
Healios K.K. Revenue
Healios K.K. had revenue of 19.00M JPY in the quarter ending September 30, 2025, a decrease of -44.12%. This brings the company's revenue in the last twelve months to 97.00M, down -82.33% year-over-year. In the year 2024, Healios K.K. had annual revenue of 560.00M with 362.81% growth.
Revenue (ttm)
97.00M
Revenue Growth
-82.33%
P/S Ratio
433.08
Revenue / Employee
1.49M
Employees
65
Market Cap
42.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 560.00M | 439.00M | 362.81% |
| Dec 31, 2023 | 121.00M | 31.00M | 34.44% |
| Dec 31, 2022 | 90.00M | 49.00M | 119.51% |
| Dec 31, 2021 | 41.00M | 14.00M | 51.85% |
| Dec 31, 2020 | 27.00M | -252.00M | -90.32% |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takara Bio | 44.08B |
| Nxera Pharma | 28.70B |
| GNI Group | 25.78B |
| RaQualia Pharma | 3.05B |
| Japan Tissue Engineering | 2.26B |
| AnGes | 818.00M |
| Cuorips | 360.00M |
| Renascience | 87.00M |